YaoShi Medical raises tens of millions CNY in Series A+ funding to accelerate the commercialization of its advanced ophthalmic devices and expand its market presence.

Target Information

耀视（苏州）医疗科技有限公司, commonly referred to as YaoShi Medical, has successfully raised tens of millions CNY in its Series A+ funding round, led by YuanHe PuHua and supported by HaiHong JinLi. This investment will primarily be utilized to accelerate the commercialization of its core product, the Scanning Laser Ophthalmoscope (SLO), alongside the development of various innovative ophthalmic optical devices. YaoShi Medical specializes in the innovation of ophthalmic medical instruments and combines research, production, sales, and AI big data research within its operations.

The company's dedicated technical team boasts nearly 20 years of experience within major international ophthalmic equipment firms and has established technological prowess in core image processing, optical design, industrialization, and engineering. Currently, YaoShi Medical operates R&D centers in Suzhou, Nantong, and Japan, focusing on innovative diagnostic and screening techniques targeted toward the ophthalmic sector.

Industry Overview

The ophthalmic healthcare market in China is evolving rapidly, driven by two significant trends: an increase in patient demographics and a rising prevalence of eye diseases due to an aging population and lifestyle chang